Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients

Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients

Abstract Background Indacaterol maleate delivered with the Breezhaler® inhalation device is a long-acting β2-agonist approved for chronic obstructive pulmonary disease. In the development of a once daily, inhaled fixed dose combination (FDC) of indacaterol, glycopyrronium bromide (a long-acting musc...

Full description

Bibliographic Details
Main Authors: David Miller, Soniya Vaidya, Juergen Jauernig, Brian Ethell, Kristina Wagner, Rajkumar Radhakrishnan, Hanns-Christian Tillmann
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Respiratory Research
Subjects:
Asthma
Pharmacokinetic
Pharmacodynamics
Efficacy
LABA
Randomised control trial
Online Access:http://link.springer.com/article/10.1186/s12931-020-01501-1

Internet

http://link.springer.com/article/10.1186/s12931-020-01501-1

Similar Items